Patent details
EP3490560
Title:
NIRAPARIB FOR USE IN A METHOD OF TREATING PROSTATE CANCER
Basic Information
- Publication number:
- EP3490560
- PCT Application Number:
- US2017044413
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP177542263
- PCT Publication Number:
- WO2018023017
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- NIRAPARIB FOR USE IN A METHOD OF TREATING PROSTATE CANCER
- French Title of Invention:
- NIRAPARIB POUR SON UTILISATION DANS UNE MÉTHODE DE TRAITEMENT DU CANCER DE LA PROSTATE
- German Title of Invention:
- NIRAPARIB ZUR VERWENDUNG IN EINEM VERFAHREN ZUR BEHANDLUNG VON PROSTATAKREBS
- SPC Number:
-
LUC50015
Dates
- Filing date:
- 28/07/2017
- Grant date:
- 22/01/2025
- EP Publication Date:
- 05/06/2019
- PCT Publication Date:
- 01/02/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 22/01/2025
- EP B1 Publication Date:
- 22/01/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 28/07/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 24/10/2025
-
-
- Name:
- Janssen Pharmaceutica NV
- Address:
- Turnhoutseweg 30, 2340 Beerse, Belgium (BE)
History of Owners
- From:
- 25/09/2025
- To:
- 24/10/2025
- Name:
- Janssen Pharmaceutica NV
- Address:
- Turnhoutseweg 30, 2340 Beerse, Belgium (BE)
- From:
- 15/01/2025
- To:
- 25/09/2025
- Name:
- Janssen Pharmaceutica, N.V.
- Address:
- Turnhoutseweg 30, 2340 Beerse, Belgium (BE)
Agent
- Name:
- NOVAGRAAF BREVETS
- From:
- 28/01/2025
- Address:
- BÂTIMENT O2, 2 RUE SARAH BERNHARDT CS90017, 92665, ASNIÈRES-SUR-SEINE cedex, France (FR)
- To:
Inventor
1
- Name:
- HAWKINS, Rebecca
- Address:
- Panama (PA)
2
- Name:
- GOTTARDIS, Marco
- Address:
- United States (US)
3
- Name:
- YAMADA, Douglas H.
- Address:
- United States (US)
4
- Name:
- SNYDER, Linda
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201662368466 P
- Priority Date:
- 29/07/2016
- Priority Country:
- United States (US)
2
- Priority Number:
- 201662369239 P
- Priority Date:
- 01/08/2016
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 31/454;
A61P 35/00;
Publication
Bulletin
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2025/12
- Publication date:
- 07/11/2025
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
European Patent Bulletin
1
- Issue number:
- 202504
- Publication date:
- 22/01/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202509
- Publication date:
- 26/02/2025
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
3
- Issue number:
- 202548
- Publication date:
- 26/11/2025
- Description:
- Change of owner's name or address
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of owner(s) name/address
- Deed Number:
- RC20250000352A
- Date Registered:
- 25/09/2025
- Licence Effective Date:
-
- Licence Expiration Date:
-
- Scope of Licence:
-
- Deed Filer:
-
Dennemeyer & Associates S.A.
- Journal Edition Number:
-
- Text:
- changement de nom
- Country Code:
-
- Updated Licence Number:
-
- Terminated Licence Number:
-
Added Owner(s)
- Name:
- Janssen Pharmaceutica NV
- Address:
- Turnhoutseweg 30, 2340 Beerse, Belgium (BE)
Removed Pledgee
- Name:
-
- Address:
Annual Fees
- Annual Fee Due Date:
- 31/07/2026
- Annual Fee Number:
- 10
- Annual Fee Amount:
- 131 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 14/07/2025
- Last Annual Fee Paid Number:
- 9
- Last Annual Fee Paid Amount:
- 115 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM